Table of Contents
Introduction And Abbreviations
-
- Introduction
- Other Relevant Reports
- Definition
- Abbreviations & Terms
- Abbreviations
- Terms
Executive Summary
-
- Baby boomers and seniors are major drivers for analgesics market
- Babies and toddler formulations grow sales
- Specific symptom pain relief could generate new customers
- OTC vs. prescription drugs
- Prevention may be the best medicine
- Targeting a specific type of pain
- Big gains in external analgesics market
- Interest in alternative products
- A $2.2 billion market
- Delivery systems distinguish segments
- Four big players and store brands account for most sales
- McNeil is biggest spender on media
- Drug stores edge out supermarkets for sales in 2003
- Respondents are more likely to use extra strength products
- Two thirds of respondents take pain killers for headaches
- Drug stores and supermarkets favorite purchase sites
- Future trends
- Analgesics forecast to decline
Market Drivers
-
- Aging population boosts market
-
- Figure 1: U.S. population projections, 1998, 2003 and 2008
- More products for children
- Incidence of specific ailments
-
- Figure 2: Prevalence of specific conditions/ailments among population aged 18 and older, by percent of population, 2001
- OTC and prescription drug use
-
- Figure 3: Usage of OTC vs. prescription drugs for specific ailments, January-September 2003
- Prophylactic uses of analgesics
- Analgesics targeting specific pain symptoms
- Competition from other products
- External analgesics
- Alternative medicines
Market Size & Trends
-
-
- Figure 4: Total U.S. retail sales of analgesic products, at current and constant prices, 1998-2003*
- Graph 1: Total U.S. retail sales of internal analgesic products, at current and constant prices, 1998-2003*
-
Market Segmentation
-
-
- Figure 5: Sales of analgesics, segmented by delivery system, 2001 and 2003*
- Analgesic tablets
-
- Figure 6: Sales of analgesic tablets, at current and constant prices, 1998-2003*
- Analgesic liquids
-
- Figure 7: Sales of analgesic liquids, at current and constant prices, 1998-2003*
-
Supply Structure
-
- COMPANIES AND BRANDS
-
- Figure 8: Manufacturer sales of internal analgesic products in the U.S., 2001 & 2003*
- Analgesic tablets
-
- Figure 9: Manufacturer brand sales of internal analgesic tablets in the U.S., 2001 and 2003*
- Analgesic liquids
-
- Figure 10: Manufacturer brand sales of internal analgesic liquids in the U.S., 2001 & 2003*
- Profiles of Major Manufacturers
- McNeil Consumer Products (Johnson & Johnson)
- Wyeth
- Bayer Consumer Health Division International
- Bristol Myers-Squibb
Advertising & Promotion
-
- McNeil Consumer Products
- Bayer Consumer Health Division International
- Bristol Myers-Squibb
- Wyeth
Retail Distribution
-
- Introduction
-
- Figure 11: U.S. retail sales of internal analgesic products, by channel, 2001 and 2003*
- Drug stores
-
- Figure 12: U.S. drug store sales of internal analgesics, at current and constant prices, 1998-2003
- Drug store operating data
-
- Figure 13: Top drug store operating statistics, latest fiscal year-end
- Figure 14: Percentage change from latest fiscal year-end versus year prior
- Supermarkets
-
- Figure 15: U.S. supermarket sales of internal analgesics, at current and constant prices, 1998-2003
- Supermarket operating data
-
- Figure 16: Top supermarket operating statistics, latest fiscal year-end
- Figure 17: Percentage change from latest fiscal year-end versus year prior
The Consumer
-
- Introduction
- Usage of analgesics
-
- Figure 18: Usage of OTC analgesics, January 2003-September 2003
-
- Figure 19: Usage of OTC analgesics, by gender, January 2003-September 2003
-
- Figure 20: Usage of OTC analgesics, by age, January 2003-September 2003
-
- Figure 21: Usage of OTC analgesics, by race/ethnicity, January 2003-September 2003
- Types of analgesics used
-
- Figure 22: Types of analgesics used, January 2003-September 2003
-
- Figure 23: Types of analgesics used, by age, January 2003-September 2003
-
- Figure 24: Types of analgesics used, by race/ethnicity, January 2003-September 2003
- Forms of analgesics used
-
- Figure 25: Forms of analgesics used, January 2003-September 2003
-
- Figure 26: Forms of analgesics used, by age, January 2003-September 2003
-
- Figure 27: Forms of analgesics used, by race/ethnicity, January 2003-September 2003
- Reasons for using OTC analgesics
-
- Figure 28: Ailments for which OTC analgesics are used, January 2003-September 2003
-
- Figure 29: Ailments for which OTC analgesics are used, by gender, January 2003-September 2003
-
- Figure 30: Ailments for which OTC analgesics are used, by age, January 2003-September 2003
-
- Figure 31: Ailments for which OTC analgesics are used, by race/ethnicity, January 2003-September 2003
- Purchase venues for OTC analgesics
-
- Figure 32: Purchase venues for OTC pain relievers, May 2004
-
- Figure 33: Purchase venues for OTC pain relievers, by age, May 2004
-
- Figure 34: Purchase venues for OTC pain relievers, by household income, November 2000
-
- Figure 35: Purchase venues for OTC pain relievers, by race/ethnicity, November 2000
- Interest in new forms of analgesics
-
- Figure 36: Interest in new forms of pain relievers, May 2004
-
- Figure 37: Interest in new forms of pain relievers, by age, May 2004
-
- Figure 38: Interest in new forms of pain relievers, by household income, May 2004
- Attitudes and opinions concerning analgesics
-
- Figure 39: Attitudes towards analgesics, May 2004
-
- Figure 40: Attitudes towards analgesics, by age, May 2004
- Analgesics and health issues
-
- Figure 41: Knowledge of potential risk of mixing acetominophen and alcohol, May 2004
-
- Figure 42: Knowledge of potential risk of mixing acetominophen and alcohol, by age, May 2004
- Opinions concerning OTC and prescription medications
-
- Figure 43: Attitudes towards OTC vs. prescription medications, January 2003-September 2003
-
- Figure 44: Attitudes towards OTC vs. prescription medications, by age, January 2003-September 2003
-
- Figure 45: Attitudes towards OTC vs. prescription medications, by race/ethnicity, January 2003-September 2003
- Summary
Future & Forecast
-
- FUTURE TRENDS
- Aging population will help drive sales
- Interest in children’s products will also continue
- Specific ailments require specific treatments
- Prophylactic usage of analgesics may drive market
- Competition
- MARKET FORECAST
- Analgesics
-
- Figure 46: Forecast of total U.S. retail sales of analgesic products, at current and constant prices, 2003-2008
-
- Graph 2: Sales of analgesics at current prices, 1998-2008
- Analgesic Tablets
-
- Figure 47: Forecast of U.S. sales of analgesic tablets, at current and constant prices, 2003-2008
- Analgesic Liquids
-
- Figure 48: Forecast of U.S. sales of analgesic liquids, at current and constant prices, 2003-2008
- Forecast Factors
Appendix: Trade Associations
Appendix: New Product Briefs
-
- Chattem: Pamprin All Day Maximum Strength Pain Reliever
- McNeil Consumer Products: Tylenol Extra Strength Cool Caplets
- McNeil Consumer Products: Tylenol Arthritis Pain Extended Pain Relief
- Bayer: Bayer Children’s Genuine Aspirin Chewable Tablets
- Bayer: Bayer Safety Coated Aspirin
- Bayer: Bayer Mint Flavor Chewable Aspirin
- Bayer: Bayer Women’s Aspirin
- Bristol Myers-Squibb: Excedrin Tension Headache
Back to top